A multicentre US study found rapid ganglion cell complex (GCC) thinning in glaucoma patients was associated with faster rates of central visual-field decline. Researchers led by Dr Golnoush
US biotechnology company Trefoil Therapeutics has dosed the first patient in its phase 1 study evaluating TTHX1114, a topical eye drop designed to reduce the duration and impact of corneal epithelial
Following cataract surgery, aphakic children who received a secondary intraocular lens (IOL) had a lower glaucoma risk than those who did not, according to a US study. Dr Serena Wang, University of
German researchers found closing full-thickness macular holes with heavy silicone oil tamponade in secondary surgery to be safe and efficient. Led by Dr Tibor Lohmann, RWTH Aachen University,
Researchers have uncovered five genetic variants which increase a person’s myopia risk the longer they stay in school.
California-based ophthalmic medical company Glaukos announced promising topline results from its phase 2a first-in-human clinical trial for GLK-301 (iLution), a sterile topical cream to treat dry eye disease (DED). The cream formulation acts as a depot allowing pilocarpine to be delivered through th
The Tarsus Eyelid Patch, designed by US startup Nictavi for effective and comfortable eye closure, is now available in New Zealand.
The New Zealand Regulations Review Committee (RRC) rejected the Royal Australian and New Zealand College of Ophthalmologists’ (RANZCO) complaint about the Optometrists and Dispensing Opticians Board’s (ODOB) specialist optometrist scope of practice – ophthalmic laser surgeries, and its associated pr
To end Australian optometry’s “health data drought”, Optometry Australia (OA) is urging practices to participate in its nationwide data-collection drive.
University of Auckland Professor Helen Danesh-Meyer has been made a Companion of the New Zealand Order of Merit (CNZM) for her services to ophthalmology in the King’s 2023 New Year honours list.
Sarah Berman is the new general manager for Macular Degeneration New Zealand (MDNZ), replacing Anna Crane, who stepped down after two years in the role.
The Ocular Therapeutics Conference (OTC) is returning to its pre-Covid, one-day conference format on Sunday 12 February at the University of Auckland’s Grafton Campus.
